Category: 23andMe Research

Incorporating Technology and DNA Testing into Clinical Trials

Many expensive clinical trials fail because the therapy causes harmful side effects in some or all participants or the drug isn’t effective across the board. Genetics may explain differences in response, but as of today DNA testing isn’t a standard part of clinical trials. Integrating genetic testing into ...

Read more

Participating in Genetic Research

Not all cancers are created equal. Ask anyone with metastatic breast cancer. For the 155,000 women in the United States living with this diagnosis, each day represents a constant fight against a cancer that has spread into other parts of their bodies — most often their bones, liver, lungs or brain. With ...

Read more

An Active Participant in Breast Cancer Research and in Life

Editors note June 2013: Suzan "Suzie" Mickey lost her battle with cancer earlier this month. An advocate for better treatments for women with metastatic breast cancer, Suzie inspired many with her attitude. Our condolences go out to her family. Positive, helpful, and upbeat. These aren’t words you would ...

Read more

Participating in Metastatic Breast Cancer Research

Earlier this year 23andMe and Genentech launched an online study of metastatic breast cancer to learn more about how genes might play a role in how a person responds to bevacizumab, also known as Avastin®. (Avastin® is not approved by the FDA for treatment of metastatic breast cancer.) Since women began to ...

Read more

Highlighting 23andMe Research

Team 23andMe will again have a strong presence at the annual meeting of the American Society of Human Genetics. We’ve been at this gathering of geneticists and those interested in human genetics ever since 23andMe launched, but this year with the 62nd annual meeting being held in San Francisco — sort of ...

Read more

A Milestone in Sarcoma Research

Each person who has joined 23andMe’s Sarcoma research community has their own reasons for participating, but they all share the same hopes that we have — to find the causes for sarcoma and new treatments for this rare cancer. Earlier this month, 23andMe took an important step in that direction when we ...

Read more

23andMe’s Parkinson’s Community is Almost There

23andMe's Emily Drabant, PhD, speaking at a Parkinson's event in Iowa. 23andMe is tantalizingly close to reaching the goal of enrolling 10,000 patients in our Parkinson’s research community. We’re past the 8,000 mark and the pace of enrollment is now more than two-and-a-half times what was a year ago, but ...

Read more

Breast Size Matters — But Not In The Way You Think

With Nick Eriksson Social norms and preferences aside, it turns out that breast size matters -- but not quite in the way you think. 23andMe’s latest research paper, published in the journal BMC Medical Genetics, shows that genetic factors influence whether women have double As or double Ds. This might ...

Read more

Why Not Participate? One Patient’s Perspective

This post first ran a few days ago on the Michael J. Fox Foundation blog. We liked it so much we're re-posting it here. Please take a look and, if you have Parkinson's, think about joining Gary and thousands of others and sign up and be part of our Parkinson's research community. By Lauren Anderson For ...

Read more

Oldest vs. Youngest — Let the Sibling Rivalries Begin!

Ever felt like your studious oldest sibling was more responsible? Or that your rebellious younger sibling always got the most attention? Our latest quiz questions our thoughts about the effects birth order has on personality, accomplishment, and life choices. This quiz is now closed. See the answers ...

Read more

Return to top